Can intestinal ultrasound redefine bowel damage assessment in Crohn’s disease? Discover key insights from the EXTENT Study and expert consensus on IUS. Watch the full video here: youtu.be/v_D6o-e8KkU . . . #CrohnsDisease #IUS #Gastroenterology

✅ Editorial Recommendations – June 2026 This month, @ibd_enc spotlights 6 key studies on cognitive health, intestinal ultrasound, precision nutrition, genetic risk, value-based care, and microbiome therapies in IBD. 👉 Read more: ibdenc.org/ibd-journal #IBDENC #IBDResearch

Marking World IBD Day, AIG Hospitals and IBDENC proudly introduce the IBDENC Journal - a new step forward in promoting research, knowledge sharing, and collaboration in Inflammatory Bowel Disease. Advancing awareness. Inspiring innovation. Improving patient care. #WorldIBDDay #AIGHospitals #IBDENC #IBDJournal #IBDAwareness

On #WorldIBDDay, AIG Hospitals and IBDENC are proud to launch the IBDENC Journal - a platform to advance research, education, and collaboration in Inflammatory Bowel Disease. Together, driving innovation and better patient care. @DrRupaBanerjee1 @drvishal82 @wingyanjoyce

Today at AIG Hospitals, we proudly celebrated World IBD Day alongside our patients, caregivers, doctors, and healthcare teams 💜 With the message ‘IBD Has No Borders,’ we came together to spread awareness, share patient voices, and strengthen hope for everyone living with Inflammatory Bowel Disease. Every story matters, every patient matters, and together we move toward better care and support for all. #AIGHospitals #WorldIBDDay #IBDAwareness #CrohnsDisease #GutHealth #HealthAwareness #HealthyGut #Healthcare #Awareness #AIGCares #IBD

And it's a wrap @DDWMeeting #Chicago fortunate to have presented our work on perianal Crohn's Infront of the global audience. Thanks to @DrRupaBanerjee1 for the support and encouragement. @YOGI_IBD @ibd_enc @AIGHospitals

✅ @ibd_enc 's Editorial Recommendations – May 2026 7 key IBD studies: IUS predicts response | IUS in pediatric CD | IUS bowel damage params | UST vs TOFA UC | UST pediatric CD | UST stricturing CD | Emulsifiers & gut 👉 ibdenc.org #IBD #IBDENC

Severe ulcerative colitis doesn’t always mean surgery. New research shows how personalized infliximab therapy can help doctors predict risk and improve outcomes. 👉Watch now: youtu.be/nnKXzGH2a18 . . . . #IBD #UlcerativeColitis #Infliximab #Gastroenterology @ibd_enc

@ibd_enc 's Editorial Recommendations – April 2026 -Statins ↓ stricture risk in Crohn’s -Personalized infliximab in ASUC -UST vs IFX in perianal CD -Rising IBD burden in India -Updated surveillance guidelines More at: ibdenc.org/ibd-journal #IBD #Gastroenterology #MedTwitter

AI is transforming IBD clinical trials. Explore the IOIBD consensus on using AI for endoscopic & histologic assessment-improving accuracy, efficiency & reproducibility while supporting clinicians. ▶️Watch: youtu.be/47FKA9of4YA Source: JCC (Oxford Academic) #IBD #MedTwitter #Ai

🚀 The IUS Preceptorship in IBD, organized by the Dept. of IBD, AIG Hospitals, brings experts together to advance IUS in IBD care. 📸 Glimpses from the workshop #AIGHospitals #IBDENC #IUS #IBD #MedEd

Cyclic exclusive enteral nutrition (EEN) may sustain drug-free remission in paediatric Crohn’s disease. CD-HOPE trial: lower relapse with cyclic EEN vs PEN (49% vs 76%) over 12 months. Supports a nutrition-led, non-pharmacologic maintenance strategy. youtu.be/3wbytQLWOHo

Editorial Recommendations: March-26 @ibd_enc highlights 5 key studies: JAK inhibitors in ASUC, Mirikizumab for paediatric UC (SHINE-1), 10-year LIR!C trial follow-up, AI in IBD trial endpoints (IOIBD consensus), and the Mediterranean diet in IBD. 🔎More: ibdenc.org

Longer steroid taper (10 vs 6 weeks) improves steroid-free remission at 6 months in moderate–severe ulcerative colitis, with similar safety in a randomized trial. Know more: youtu.be/_QhfpqTFsFA . . #UlcerativeColitis #ClinicalTrials #WileyOnlineLibrary #APTjournal #IBDENC

Registrations open for the AIG IUS Preceptorship in IBD 2026 at AIG Hospitals. Learn intestinal ultrasound from global experts Kerri Novak & Shintaro Sagami. 📅Mar 23–28 | Jun 22–27 Limited seats. Register: forms.office.com/r/QLiLYhca2… #IBDExpertise #IntestinalUltrasound #Gastro #IUS

Earlier may be better in Crohn’s disease. A phase 4 study shows vedolizumab achieves higher combined clinical & endoscopic remission (31.4% vs 8.6%) and fewer serious AEs when used within 2 years of diagnosis. 👉See more: youtu.be/Axt2yuFhdyM #CrohnsDisease #Vedolizumab #IBD

Editorial Recommendations – Feb 2026 IBD-ENC spotlights 5 key studies: steroid tapering in UC, EEN vs PEN in paediatric CD, appendicectomy vs JAK after biologic failure, eccDNA as an IBD biomarker, and consensus on upper GI Crohn’s. More: ibdenc.org

👉Watch Now: youtu.be/_8TiAeSbVB4 Emerging evidence shows the Oral Microbiome plays a critical role in inflammatory bowel disease. This editorial explores new mechanisms, systemic implications, and how this science may reshape best-practice care for IBD.

Key moments from IBDENC– The Madras Consensus, including collaborative discussions on advanced IBD care and the launch of The IBDENC Journal. #IBDENC #MadrasConsensus #IBDManagement #AdvancedIBD #MedicalConference #ScientificCollaboration #IBDJournal @DrRupaBanerjee1 @pardus125

IBD Journal Recommendations – Jan 2026 We highlight 5 key studies shaping IBD care-from early vedolizumab use to novel oral therapies, PSC-IBD insights, cancer risk, and updated 5-ASA strategies. More at: ibdenc.org/ibd-journal #IBD #CrohnsDisease #UlcerativeColitis #IBDResearch